Literature DB >> 25122676

Pharmacological chaperones in the age of proteomic pathology.

Scott A Small1.   

Abstract

Mesh：

Substances：

Year:  2014        PMID： 25122676      PMCID： PMC4151756          DOI： 10.1073/pnas.1413111111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN： 0027-8424            Impact factor:   11.205


× No keyword cloud information.
  13 in total

Review 1.  Pharmacological chaperones: a new twist on receptor folding.

Authors:  J P Morello; U E Petäjä-Repo; D G Bichet; M Bouvier
Journal:  Trends Pharmacol Sci       Date:  2000-12       Impact factor: 14.819

Review 2.  The druggable genome.

Authors:  Andrew L Hopkins; Colin R Groom
Journal:  Nat Rev Drug Discov       Date:  2002-09       Impact factor: 84.694

3.  Structure of acid beta-glucosidase with pharmacological chaperone provides insight into Gaucher disease.

Authors:  Raquel L Lieberman; Brandon A Wustman; Pedro Huertas; Allan C Powe; Corey W Pine; Richie Khanna; Michael G Schlossmacher; Dagmar Ringe; Gregory A Petsko
Journal:  Nat Chem Biol       Date:  2006-12-24       Impact factor: 15.040

Review 4.  The persisting challenge of selective and specific proteasome inhibition.

Authors:  Michael Groll; Robert Huber; Luis Moroder
Journal:  J Pept Sci       Date:  2009-02       Impact factor: 1.905

5.  Computational approaches to identifying and characterizing protein binding sites for ligand design.

Authors:  Stefan Henrich; Outi M H Salo-Ahen; Bingding Huang; Friedrich F Rippmann; Gabriele Cruciani; Rebecca C Wade
Journal:  J Mol Recognit       Date:  2010 Mar-Apr       Impact factor: 2.137

Review 6.  Locating and characterizing binding sites on proteins.

Authors:  C Mattos; D Ringe
Journal:  Nat Biotechnol       Date:  1996-05       Impact factor: 54.908

7.  Potential pharmacological chaperones targeting cancer-associated MCL-1 and Parkinson disease-associated α-synuclein.

Authors:  Misook Oh; Ji Hoon Lee; Wei Wang; Hui Sun Lee; Woo Sirl Lee; Christopher Burlak; Wonpil Im; Quyen Q Hoang; Hyun-Suk Lim
Journal:  Proc Natl Acad Sci U S A       Date:  2014-07-14       Impact factor: 11.205

8.  Model-guided microarray implicates the retromer complex in Alzheimer's disease.

Authors:  Scott A Small; Kelly Kent; Aimee Pierce; Conrad Leung; Min Suk Kang; Hirokazu Okada; Lawrence Honig; Jean-Paul Vonsattel; Tae-Wan Kim
Journal:  Ann Neurol       Date:  2005-12       Impact factor: 10.422

Review 9.  Neuroscience in the era of functional genomics and systems biology.

Authors:  Daniel H Geschwind; Genevieve Konopka
Journal:  Nature       Date:  2009-10-15       Impact factor: 49.962

10.  What are pharmacological chaperones and why are they interesting?

Authors:  Dagmar Ringe; Gregory A Petsko
Journal:  J Biol       Date:  2009-10-13
View more
  3 in total

Review 1.  The use of pharmacological retromer chaperones in Alzheimer's disease and other endosomal-related disorders.

Authors:  Diego E Berman; Dagmar Ringe; Greg A Petsko; Scott A Small
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

2.  DDIEM: drug database for inborn errors of metabolism.

Authors:  Marwa Abdelhakim; Eunice McMurray; Ali Raza Syed; Senay Kafkas; Allan Anthony Kamau; Paul N Schofield; Robert Hoehndorf
Journal:  Orphanet J Rare Dis       Date:  2020-06-11       Impact factor: 4.123

3.  Mechanistic Insights into the Chaperoning of Human Lysosomal-Galactosidase Activity: Highly Functionalized Aminocyclopentanes and C-5a-Substituted Derivatives of 4-epi-Isofagomine.

Authors:  Patrick Weber; Martin Thonhofer; Summer Averill; Gideon J Davies; Andres Gonzalez Santana; Philipp Müller; Seyed A Nasseri; Wendy A Offen; Bettina M Pabst; Eduard Paschke; Michael Schalli; Ana Torvisco; Marion Tschernutter; Christina Tysoe; Werner Windischhofer; Stephen G Withers; Andreas Wolfsgruber; Tanja M Wrodnigg; Arnold E Stütz
Journal:  Molecules       Date:  2020-09-03       Impact factor: 4.411
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.